China · Series B startup
Funding summaryUpdated 26 Oct 2026
$42Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Northern Light Venture CapitalReported by DealStreetAsia
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Northern Light Venture CapitalCMB International Capital Corporation LimitedL
HSG
ARCH Venture PartnersMatrix Partners ChinaLilly Asia VenturesSequoia Capital ChinaMissing a round, or an investor who was in one? Tell us.
This firm lists Qihan Biotech as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Qihan Biotech's investors include Northern Light Venture Capital, CMB International Capital Corporation Limited, HSG, ARCH Venture Partners and Matrix Partners China, and 2 more on record.
Qihan Biotech has raised $42M across 2 rounds since 2019.
Qihan Biotech's most recent round was a Series B of $16M in Sept 2023.
Qihan Biotech's largest round on record is $26M (Series A), in Sept 2019, led by CMB International Capital Corporation Limited.
Qihan Biotech's first round on record, in Sept 2019, was backed by CMB International Capital Corporation Limited, Northern Light Venture Capital and Sequoia Capital China.
Qihan Biotech's latest named round is a Series B, in Sept 2023.
Qihan Biotech is based in China.
CMB International Capital Corporation Limited led the Series A in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
China · 
